Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

C4 Therapeutics (CCCC) Cash from Operations (2019 - 2026)

C4 Therapeutics has reported Cash from Operations over the past 8 years, most recently at 29944000.0 for Q1 2026.

  • For Q1 2026, Cash from Operations rose 10.04% year-over-year to 29944000.0; the TTM value through Mar 2026 reached 95353000.0, down 18.71%, while the annual FY2025 figure was 98694000.0, 51.47% down from the prior year.
  • Cash from Operations for Q1 2026 was 29944000.0 at C4 Therapeutics, down from 22145000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 4974000.0 in Q2 2024 and troughed at 33285000.0 in Q1 2025.
  • A 5-year average of 23916000.0 and a median of 24133000.0 in 2024 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: skyrocketed 73.82% in 2024 and later tumbled 142.4% in 2025.
  • Year by year, Cash from Operations stood at 29128000.0 in 2022, then grew by 17.57% to 24009000.0 in 2023, then grew by 25.31% to 17932000.0 in 2024, then decreased by 23.49% to 22145000.0 in 2025, then plummeted by 35.22% to 29944000.0 in 2026.
  • Business Quant data shows Cash from Operations for CCCC at 29944000.0 in Q1 2026, 22145000.0 in Q4 2025, and 31207000.0 in Q3 2025.